Remicade and Glioblastoma - a phase IV clinical study of FDA data


Glioblastoma is found among people who take Remicade, especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years.

The phase IV clinical study analyzes which people take Remicade and have Glioblastoma. It is created by eHealthMe based on reports of 201,081 people who have side effects when taking Remicade from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 07, 2022

201,081 people reported to have side effects when taking Remicade.
Among them, 51 people (0.03%) have Glioblastoma.

What is Remicade?

Remicade has active ingredients of infliximab. It is often used in crohn's disease. eHealthMe is studying from 202,391 Remicade users for its effectiveness, alternative drugs and more.

What is Glioblastoma?

Glioblastoma (most common and most aggressive malignant primary brain tumour in humans) is found to be associated with 481 drugs and 262 conditions by eHealthMe.

Number of Remicade and Glioblastoma reports submitted per year:

Could Remicade cause Glioblastoma?

Time on Remicade when people have Glioblastoma *:

  • < 1 month: 6.25 %
  • 1 - 6 months: 12.5 %
  • 6 - 12 months: 12.5 %
  • 1 - 2 years: 18.75 %
  • 2 - 5 years: 12.5 %
  • 5 - 10 years: 37.5 %
  • 10+ years: 0.0 %

Gender of people who have Glioblastoma when taking Remicade *:

  • female: 58.14 %
  • male: 41.86 %

Age of people who have Glioblastoma when taking Remicade *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 5.13 %
  • 30-39: 2.56 %
  • 40-49: 10.26 %
  • 50-59: 38.46 %
  • 60+: 43.59 %

Common drugs people take besides Remicade *:

  1. Methotrexate: 6 people, 11.76%
  2. Enbrel: 3 people, 5.88%
  3. Folic Acid: 3 people, 5.88%
  4. Orencia: 3 people, 5.88%
  5. Prednisolone: 2 people, 3.92%
  6. Humira: 2 people, 3.92%
  7. Isoniazid: 2 people, 3.92%
  8. Voltaren: 2 people, 3.92%
  9. Ambien: 2 people, 3.92%
  10. Prednisone: 2 people, 3.92%

Common side effects people have besides Glioblastoma *:

  1. Death: 3 people, 5.88%
  2. Glioma (a type of tumour that starts in the brain or spine): 2 people, 3.92%
  3. Pneumonia Aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree): 2 people, 3.92%
  4. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 3.92%
  5. Weight Increased: 1 person, 1.96%
  6. Balance Disorder: 1 person, 1.96%
  7. Cellulitis (infection under the skin): 1 person, 1.96%
  8. Central Nervous System Lymphoma (cancer of central nervous system forms in lymph tissue): 1 person, 1.96%
  9. Coordination Abnormal (abnormal movement): 1 person, 1.96%
  10. Cough: 1 person, 1.96%

Common conditions people have *:

  1. Ankylosing Spondylitis (type of arthritis affecting the spine): 7 people, 13.73%
  2. High Blood Pressure: 2 people, 3.92%
  3. Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 1.96%
  4. Stress And Anxiety: 1 person, 1.96%
  5. Spondyloarthropathy (any joint disease of the vertebral column): 1 person, 1.96%
  6. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 1.96%
  7. Nausea And Vomiting: 1 person, 1.96%
  8. Nausea (feeling of having an urge to vomit): 1 person, 1.96%
  9. Migraine (headache): 1 person, 1.96%
  10. Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 1.96%

* Approximation only. Some reports may have incomplete information.

Do you take Remicade and have Glioblastoma?

Check whether Glioblastoma is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Glioblastoma and when was it recovered:

Expand to all the drugs that have ingredients of infliximab:

Alternative drugs to, pros and cons of Remicade:

Common Remicade side effects:

Browse all side effects of Remicade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Glioblastoma treatments and more:

COVID vaccines that are related to Glioblastoma:

Common drugs associated with Glioblastoma:

All the drugs that are associated with Glioblastoma:

Common conditions associated with Glioblastoma:

All the conditions that are associated with Glioblastoma:

How the study uses the data?

The study uses data from the FDA. It is based on infliximab (the active ingredients of Remicade) and Remicade (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: